Regeneron Pharma (REGN) PT Lowered to $720 at Jefferies
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $834.04 +0.90%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Jefferies analyst Biren Amin lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $720.00 (from $730.00) while maintaining a Buy rating.
You May Also Be Interested In
- FDA approves Regeneron's Pasatru for rare bone disorder FOP
- Regeneron Announces Investor Conference Presentations
- Walmart (WMT) PT Lowered to $125 at JPMorgan, Overweight Rating Maintained as 'Short Case Feels Greedy'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
